Stimulation of endothelin-1 release by low density and very low density lipoproteins in cultured human endothelial cells
References (34)
- et al.
The role of altered lipoproteins in the pathogenesis of atherosclerosis
Am. Heart J.
(1987) - et al.
The endothelin peptides ET-I, ET-2, ET-3 and sarafotoxin S6b are co-mitogenic with platelet-derived growth factor for vascular smooth muscle cells
Atherosclerosis
(1990) - et al.
Increased plasma immunoreactive endothelin-1 concentration in hypercholesterolemic rats
Atherosclerosis
(1991) - et al.
Plasma immunoreactive endothelin in essential hypertension
Am. J. Med.
(1990) - et al.
Modified low density lipoproteins activate human macrophages to secrete immunoreactive endothelin
FEBS Lett.
(1991) - et al.
Secretory mechanism of immunoreactive endothelin in cultured bovine endothelial cells
Biochem. Biophys. Res. Commun.
(1989) - et al.
Endothelin stimulates c fos and c-myc expression and proliferation of vascular smooth muscle cells
FEBS Lett.
(1988) - et al.
Endothelin is a potent mitogen for rat vascular smooth muscle cells
Atherosclerosis
(1989) - et al.
LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture
Atherosclerosis
(1979) - et al.
Phosphatidylinositol turnover in human monocyte-derived macrophages by native and acetyl LDL
FEBS Lett.
(1989)
Modifications of low-density lipoprotein that increase its atherogenicity
N. Engl. J. Med.
(1989)
Role of biologically modified low-density lipoprotein in atherosclerosis
Am. J. Cardiol.
(1989)
The pathogenesis of atherosclerosis
N. Engl. J. Med.
(1976)
The pathogenesis of atherosclerosis: an update
N. Engl. J. Med.
(1986)
Developmental mechanisms underlying pathology of arteries
Physiol. Rev.
(1990)
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
Nature
(1988)
Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis
N. Engl. J. Med.
(1991)
Cited by (0)
Copyright © 1993 Published by Elsevier Ltd.